Cardiac Risk-Informed Treatment of EGFR-Mutant Lung Cancer With Osimertinib
[Figure: see text]
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352321/ https://www.ncbi.nlm.nih.gov/pubmed/34396180 http://dx.doi.org/10.1016/j.jaccao.2019.11.011 |
_version_ | 1783736154856620032 |
---|---|
author | Piper-Vallillo, Andrew J. Sequist, Lecia V. |
author_facet | Piper-Vallillo, Andrew J. Sequist, Lecia V. |
author_sort | Piper-Vallillo, Andrew J. |
collection | PubMed |
description | [Figure: see text] |
format | Online Article Text |
id | pubmed-8352321 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-83523212021-08-13 Cardiac Risk-Informed Treatment of EGFR-Mutant Lung Cancer With Osimertinib Piper-Vallillo, Andrew J. Sequist, Lecia V. JACC CardioOncol Original Research [Figure: see text] Elsevier 2019-12-17 /pmc/articles/PMC8352321/ /pubmed/34396180 http://dx.doi.org/10.1016/j.jaccao.2019.11.011 Text en © 2019 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Research Piper-Vallillo, Andrew J. Sequist, Lecia V. Cardiac Risk-Informed Treatment of EGFR-Mutant Lung Cancer With Osimertinib |
title | Cardiac Risk-Informed Treatment of EGFR-Mutant Lung Cancer With Osimertinib |
title_full | Cardiac Risk-Informed Treatment of EGFR-Mutant Lung Cancer With Osimertinib |
title_fullStr | Cardiac Risk-Informed Treatment of EGFR-Mutant Lung Cancer With Osimertinib |
title_full_unstemmed | Cardiac Risk-Informed Treatment of EGFR-Mutant Lung Cancer With Osimertinib |
title_short | Cardiac Risk-Informed Treatment of EGFR-Mutant Lung Cancer With Osimertinib |
title_sort | cardiac risk-informed treatment of egfr-mutant lung cancer with osimertinib |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352321/ https://www.ncbi.nlm.nih.gov/pubmed/34396180 http://dx.doi.org/10.1016/j.jaccao.2019.11.011 |
work_keys_str_mv | AT pipervallilloandrewj cardiacriskinformedtreatmentofegfrmutantlungcancerwithosimertinib AT sequistleciav cardiacriskinformedtreatmentofegfrmutantlungcancerwithosimertinib |